Table 2.

The cfDNA Levels in the Blood Serum of Healthy Mice and Mice with Tumors (B16, LLC, RLS₄₀) Before and After the Treatment with DNase I

Mice	Healthy, ng/mL	Tumor Type	w/t, ng/mL	DNase I, ng/mL
C57Bl	65 ± 10	B16	456 ± 82	246 ± 22
		LLC	138 ± 20	97 ± 16
CBA	168 ± 32	RLS40	300 ± 91	292 ± 89

w/t, mice with tumors receiving saline buffer; DNase I, mice with tumors receiving DNase I (0.12 mg/kg). Data were statistically analyzed using one-way ANOVA with a post hoc Tukey test. Data are presented as mean ± SE. Statistical significance p < 0.05. Statistical differences between groups p < 0.0001.